Brief: Organovo Highlights FXR314 Combination Therapy Potential and Plan

VivoSim Labs

08/11/2023 13:38

Nov 8 (Reuters) - Organovo Holdings Inc  ONVO.O :
    * ORGANOVO HIGHLIGHTS FXR314 COMBINATION THERAPY POTENTIAL
AND
PLAN
    * ORGANOVO HOLDINGS INC - INTENTION TO STUDY COMBINATION
THERAPY
IN INFLAMMATORY BOWEL DISEASE AND RELEASE DATA IN CALENDAR Q3
2024
    * ORGANOVO HOLDINGS INC: INTENTION TO STUDY COMBINATION
THERAPY IN
INFLAMMATORY BOWEL DISEASE AND RELEASE DATA IN CALENDAR Q3 2024

Source text for Eikon:  ID:nGNX94RT5g 
Further company coverage:  ONVO.O 

 ((Reuters.Briefs@thomsonreuters.com;))